Literature DB >> 2477293

Essential fatty acid treatment--effects on nerve conduction, polyol pathway and axonal transport in streptozotocin diabetic rats.

D R Tomlinson1, J P Robinson, A M Compton, P Keen.   

Abstract

This study was designed to examine the effect of dietary supplementation with essential fatty acids (evening primrose oil--5% weight:weight added to the diet) on acute neurophysiological and neurochemical defects in streptozotocin-diabetic rats. Diabetic rats, which were not given evening primrose oil, showed highly significant elevations of nerve sorbitol and fructose combined with a depletion of nerve myo-inositol. In those animals there was also a 40% reduction (p less than 0.02) in the accumulation of axonally transported substance P-like immunoreactivity proximal to a 12 h sciatic nerve ligature together with reduced motor nerve conduction velocity (13% [p less than 0.001] and 20% [p less than 0.001] in two separate experiments). Treatment of other diabetic rats with evening primrose oil prevented completely the development of the motor nerve conduction velocity deficit without affecting sorbitol, fructose or myo-inositol levels or the deficit in axonal transport of substance P. In a second experiment, treatment of diabetic rats with evening primrose oil was associated with significant attenuation of the conduction velocity deficit, but not complete prevention.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2477293     DOI: 10.1007/bf00274252

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  26 in total

1.  Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats.

Authors:  J H Mayer; D R Tomlinson
Journal:  Diabetologia       Date:  1983-11       Impact factor: 10.122

2.  Axonal transport of cholinergic transmitter enzymes in vagus and sciatic nerves of rats with acute experimental diabetes mellitus; correlation with motor nerve conduction velocity and effects of insulin.

Authors:  J H Mayer; D R Tomlinson
Journal:  Neuroscience       Date:  1983-08       Impact factor: 3.590

3.  Reversal, by treatment with an aldose reductase inhibitor, of impaired axonal transport and motor nerve conduction velocity in experimental diabetes mellitus.

Authors:  D R Tomlinson; P R Holmes; J H Mayer
Journal:  Neurosci Lett       Date:  1982-08-16       Impact factor: 3.046

4.  [Effect of streptozotocin diabetes on the in vivo conversion of gamma-linolenic and dihomo-gamma-linolenic 14C acids to arachidonic acid in the rat kidney and in the rat body].

Authors:  J P Poisson; J P Blond
Journal:  Diabete Metab       Date:  1985-10

5.  Effects of dietary gamma-linolenate supplementation on serum lipids and platelet function in insulin-dependent diabetic patients.

Authors:  J Chaintreuil; L Monnier; C Colette; P Crastes de Paulet; A Orsetti; D Spielmann; F Mendy; A Crastes de Paulet
Journal:  Hum Nutr Clin Nutr       Date:  1984-03

6.  Polyol pathway activity and myo-inositol metabolism. A suggested relationship in the pathogenesis of diabetic neuropathy.

Authors:  D Finegold; S A Lattimer; S Nolle; M Bernstein; D A Greene
Journal:  Diabetes       Date:  1983-11       Impact factor: 9.461

7.  Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition.

Authors:  K R Gillon; J N Hawthorne; D R Tomlinson
Journal:  Diabetologia       Date:  1983-10       Impact factor: 10.122

8.  The effect of aldose reductase inhibition on motor nerve conduction velocity in diabetic rats.

Authors:  D K Yue; M A Hanwell; P M Satchell; J R Turtle
Journal:  Diabetes       Date:  1982-09       Impact factor: 9.461

9.  Abnormal essential fatty acid composition of tissue lipids in genetically diabetic mice is partially corrected by dietary linoleic and gamma-linolenic acids.

Authors:  S C Cunnane; M S Manku; D F Horrobin
Journal:  Br J Nutr       Date:  1985-05       Impact factor: 3.718

10.  Defects of axonal transport in experimental diabetes that are unrelated to the sorbitol pathway.

Authors:  D R Tomlinson; G B Willars; E F Calthrop-Owen
Journal:  Exp Neurol       Date:  1987-04       Impact factor: 5.330

View more
  16 in total

1.  Prevention and reversal of motor and sensory peripheral nerve conduction abnormalities in streptozotocin-diabetic rats by the prostacyclin analogue iloprost.

Authors:  M A Cotter; K C Dines; N E Cameron
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-05       Impact factor: 3.000

Review 2.  The Potential Role of Fatty Acids in Treating Diabetic Neuropathy.

Authors:  Mark A Yorek
Journal:  Curr Diab Rep       Date:  2018-08-25       Impact factor: 4.810

3.  The effects of evening primrose oil on nerve function and capillarization in streptozotocin-diabetic rats: modulation by the cyclo-oxygenase inhibitor flurbiprofen.

Authors:  N E Cameron; M A Cotter; K C Dines; S Robertson; D Cox
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

4.  Contrasting effects of treatment with omega-3 and omega-6 essential fatty acids on peripheral nerve function and capillarization in streptozotocin-diabetic rats.

Authors:  K C Dines; M A Cotter; N E Cameron
Journal:  Diabetologia       Date:  1993-11       Impact factor: 10.122

5.  Pharmacological manipulation of vascular endothelium function in non-diabetic and streptozotocin-diabetic rats: effects on nerve conduction, hypoxic resistance and endoneurial capillarization.

Authors:  N E Cameron; M A Cotter; K C Dines; E K Maxfield
Journal:  Diabetologia       Date:  1993-06       Impact factor: 10.122

6.  Angiotensin converting enzyme inhibition prevents development of muscle and nerve dysfunction and stimulates angiogenesis in streptozotocin-diabetic rats.

Authors:  N E Cameron; M A Cotter; S Robertson
Journal:  Diabetologia       Date:  1992-01       Impact factor: 10.122

7.  Omega-6 and omega-3 fatty acids predict accelerated decline of peripheral nerve function in older persons.

Authors:  F Lauretani; S Bandinelli; B Bartali; B Benedetta; A Cherubini; A D Iorio; A Blè; V Giacomini; A M Corsi; J M Guralnik; L Ferrucci
Journal:  Eur J Neurol       Date:  2007-07       Impact factor: 6.089

8.  Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats.

Authors:  N E Cameron; M A Cotter; E K Maxfield
Journal:  Diabetologia       Date:  1993-04       Impact factor: 10.122

9.  Essential fatty acid treatment prevents nerve ischaemia and associated conduction anomalies in rats with experimental diabetes mellitus.

Authors:  E J Stevens; M J Lockett; A L Carrington; D R Tomlinson
Journal:  Diabetologia       Date:  1993-05       Impact factor: 10.122

10.  Detection of colour vision abnormalities in uncomplicated type 1 diabetic patients with angiographically normal retinas.

Authors:  K J Hardy; J Lipton; M O Scase; D H Foster; J H Scarpello
Journal:  Br J Ophthalmol       Date:  1992-08       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.